Literature DB >> 23588241

Short-chain carbohydrates and functional gastrointestinal disorders.

Susan J Shepherd1, Miranda C E Lomer, Peter R Gibson.   

Abstract

Carbohydrates occur across a range of foods regularly consumed including grains such as wheat and rye, vegetables, fruits, and legumes. Short-chain carbohydrates with chains of up to 10 sugars vary in their digestibility and subsequent absorption. Those that are poorly absorbed exert osmotic effects in the intestinal lumen increasing its water volume, and are rapidly fermented by bacteria with consequent gas production. These two effects alone may underlie most of the induction of gastrointestinal symptoms after they are ingested in moderate amounts via luminal distension in patients with visceral hypersensitivity. This has been the basis of the use of lactose-free diets in those with lactose malabsorption and of fructose-reduced diets for fructose malabsorption. However, application of such dietary approaches in patients with functional bowel disorders has been restricted to observational studies with uncertain efficacy. As all dietary poorly absorbed short-chain carbohydrates have similar and additive effects in the intestine, a concept has been developed to regard them collectively as FODMAPs (fermentable oligosaccharides, disaccharides, monosaccharides and polyols) and to evaluate a dietary approach that restricts them all. In patients with irritable bowel syndrome, there is now an accumulating body of evidence, based on observational and comparative studies, and on randomized-controlled trials that supports the notion that FODMAPs trigger gastrointestinal symptoms in patients with functional bowel disorders, and that a diet low in FODMAPs offers considerable symptom relief in the majority of patients who use it.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23588241     DOI: 10.1038/ajg.2013.96

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  63 in total

Review 1.  Is gluten a cause of gastrointestinal symptoms in people without celiac disease?

Authors:  Jessica R Biesiekierski; Jane G Muir; Peter R Gibson
Journal:  Curr Allergy Asthma Rep       Date:  2013-12       Impact factor: 4.806

Review 2.  Childhood functional abdominal pain: mechanisms and management.

Authors:  Judith Korterink; Niranga Manjuri Devanarayana; Shaman Rajindrajith; Arine Vlieger; Marc A Benninga
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2015-02-10       Impact factor: 46.802

Review 3.  Pathophysiology, Evaluation, and Management of Chronic Watery Diarrhea.

Authors:  Michael Camilleri; Joseph H Sellin; Kim E Barrett
Journal:  Gastroenterology       Date:  2016-10-20       Impact factor: 22.682

Review 4.  Treatment of abdominal pain in irritable bowel syndrome.

Authors:  Tim Vanuytsel; Jan F Tack; Guy E Boeckxstaens
Journal:  J Gastroenterol       Date:  2014-05-21       Impact factor: 7.527

5.  FODMAP diet modulates visceral nociception by lipopolysaccharide-mediated intestinal inflammation and barrier dysfunction.

Authors:  Shi-Yi Zhou; Merritt Gillilland; Xiaoyin Wu; Pornchai Leelasinjaroen; Guanpo Zhang; Hui Zhou; Bo Ye; Yuanxu Lu; Chung Owyang
Journal:  J Clin Invest       Date:  2017-11-27       Impact factor: 14.808

Review 6.  Dietary fructose intolerance, fructan intolerance and FODMAPs.

Authors:  Amy Fedewa; Satish S C Rao
Journal:  Curr Gastroenterol Rep       Date:  2014-01

Review 7.  The gut microbiome as a predictor of low fermentable oligosaccharides disaccharides monosaccharides and polyols diet efficacy in functional bowel disorders.

Authors:  Bruno P Chumpitazi
Journal:  Curr Opin Gastroenterol       Date:  2020-03       Impact factor: 3.287

8.  Randomised clinical trial: gut microbiome biomarkers are associated with clinical response to a low FODMAP diet in children with the irritable bowel syndrome.

Authors:  B P Chumpitazi; J L Cope; E B Hollister; C M Tsai; A R McMeans; R A Luna; J Versalovic; R J Shulman
Journal:  Aliment Pharmacol Ther       Date:  2015-06-24       Impact factor: 8.171

9.  Caecal pH is a biomarker of excessive colonic fermentation.

Authors:  Adam D Farmer; Sahar D Mohammed; George E Dukes; S Mark Scott; Anthony R Hobson
Journal:  World J Gastroenterol       Date:  2014-05-07       Impact factor: 5.742

Review 10.  Irritable bowel syndrome and food interaction.

Authors:  Rosario Cuomo; Paolo Andreozzi; Francesco Paolo Zito; Valentina Passananti; Giovanni De Carlo; Giovanni Sarnelli
Journal:  World J Gastroenterol       Date:  2014-07-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.